Clinical evaluation of metrizamide for neuroradiology in chilren.
Metrizamide is a nonionic water-soluble contrast medium for neuroradiological studies that is less irritating to the nervous system than other water-soluble agents. Studies in adults have shown that metrizamide has advantages over currently available media, but experience with children has been limited. Sixty-two children have had myelography or ventriculography using metrizamide. The children ranged in age from 11 days to 22 years. Technically satisfactory studies were obtained in every patient. No major complications were encountered. Minor side-effects included headache in 11 children (18%), mild nausea or vomiting in 16 children (26%), and fever in 4 children (6%). Seizures did not occur. One infant in the study subsequently died of unrelated problems; there was no evidence of arachnoiditis at postmortem examination. Metrizamide is a safe, effective contrast medium for neuroradiological use in children.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D014695:Cerebral Ventriculography; D002648:Child; D005260:Female; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008793:Metrizamide / Q000009:adverse effects*; D009192:Myelography; D009325:Nausea / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D008793:Metrizamide